skip to main content

Title: Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, Executive Summary

In early 2011, a dialogue was initiated within the Board of Directors (BOD) of the American Society for Radiation Oncology (ASTRO) regarding the future of the basic sciences of the specialty, primarily focused on the current state and potential future direction of basic research within radiation oncology. After consideration of the complexity of the issues involved and the precise nature of the undertaking, in August 2011, the BOD empanelled a Cancer Biology/Radiation Biology Task Force (TF). The TF was charged with developing an accurate snapshot of the current state of basic (preclinical) research in radiation oncology from the perspective of relevance to the modern clinical practice of radiation oncology as well as the education of our trainees and attending physicians in the biological sciences. The TF was further charged with making suggestions as to critical areas of biological basic research investigation that might be most likely to maintain and build further the scientific foundation and vitality of radiation oncology as an independent and vibrant medical specialty. It was not within the scope of service of the TF to consider the quality of ongoing research efforts within the broader radiation oncology space, to presume to consider their future potential, or tomore » discourage in any way the investigators committed to areas of interest other than those targeted. The TF charge specifically precluded consideration of research issues related to technology, physics, or clinical investigations. This document represents an Executive Summary of the Task Force report.« less
 [1] ;  [2] ;  [3] ;  [4] ;  [5] ;  [6] ;  [7] ;  [8] ;  [9] ;  [10] ;  [11] ;  [12] ;  [13] ;  [14] ;  [15] ;  [16] ;
  1. 21st Century Oncology, LLC, and the American Board of Radiology, Bethesda, Maryland (United States)
  2. Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia (United States)
  3. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York (United States)
  4. Department of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin (United States)
  5. Departments of Radiation Oncology and Medical Biophysics, Princess Margaret Cancer Center/University of Toronto, Toronto, Ontario (Canada)
  6. Department of Radiation Oncology, Norton Cancer Center, Louisville, Kentucky (United States)
  7. Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania (United States)
  8. Department of Radiation Oncology, New York University, New York, New York (United States)
  9. Departments of Radiation Oncology and Radiology, Stanford University, Stanford, California (United States)
  10. Department of Radiation Oncology, University of Pennsylvania (United States)
  11. Center for Radiation Research, Columbia University, New York, New York (United States)
  12. Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (United States)
  13. Department of Radiation Oncology, Duke University, Durham, North Carolina (United States)
  14. Department of Human Oncology, University of Wisconsin (United States)
  15. Department of Radiation Oncology, University of Michigan (United States)
  16. Department of Radiation Oncology, Oakland University, Oakland, California (United States)
Publication Date:
OSTI Identifier:
Resource Type:
Journal Article
Resource Relation:
Journal Name: International Journal of Radiation Oncology, Biology and Physics; Journal Volume: 88; Journal Issue: 1; Other Information: Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States